Combined peptides of human enterovirus 71 protect against virus infection in mice (Q43934303)

28 November 2017

Combined peptides of human enterovirus 71 protect against virus infection in mice (English)

1 reference

28 November 2017

Jiang Ning Liu

1

1 reference

28 November 2017

Wei Wang

2

1 reference

28 November 2017

Jian Ying Duo

3

1 reference

28 November 2017

Yi Hao

4

1 reference

28 November 2017

Chun Mei Ma

5

1 reference

28 November 2017

Wan Bo Li

6

1 reference

28 November 2017

Shu Zhu Lin

7

1 reference

28 November 2017

Xue Zhong Gao

8

1 reference

28 November 2017

Xiao Lin Liu

9

1 reference

28 November 2017

Yan Feng Xu

10

1 reference

28 November 2017

Wen-Bo Xu

11

1 reference

28 November 2017

Chuan Qin

12

1 reference

28 November 2017

Lian Feng Zhang

13

1 reference

28 November 2017

language of work or name

English

0 references

publication date

8 September 2010

1 reference

28 November 2017

1 reference

28 November 2017

28

1 reference

28 November 2017

46

1 reference

28 November 2017

7444-7451

1 reference

Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Enterovirus 71 outbreak, Brunei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

7 January 2021

Enterovirus 71 in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Neurodevelopment and Cognition in Children after Enterovirus 71 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Appearance of mosaic enterovirus 71 in the 2008 outbreak of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Enterovirus 71 outbreak in the People's Republic of China in 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Retrograde axonal transport: a major transmission route of enterovirus 71 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Mechanism of fulminant pulmonary edema caused by enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Autoantibodies in type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Virus-mediated autoimmunity in Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Immunopathology of RSV infection: prospects for developing vaccines without this complication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.080

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.08.080

1 reference

28 November 2017

1 reference